- HBV-specific CD8+ T cells for Sustained HBeAg Seroconversion after Lamivudine Therapy
-
Lee CK, Han KH, Suh JH, Cho YS, Won SY, Chon CY, Moon YM, Park IS
- KMID: 760578
- Korean J Hepatol.
- 2005 Mar;11(1):34-42.
BACKGROUND/AIMS: Viral suppression of the hepatitis B virus (HBV) can be induced by lamivudine, but the relapse seen in many patients after cessation of lamivudine therapy is troublesome. We... -
- CITED
-
- Close
- SHARE
-
- Close
